What the structure does Alpha-MSH is a 13-residue linear peptide, and its activity depends on a four-residue core sequence, His-Phe-Arg-Trp, which is the recognition motif the melanocortin receptors read
Tirzepatide (Zepbound) FDA-indicated for obesity and sleep apnea A dual GLP-1/GIP receptor agonist
hazard ratios 1.54-1.95) Masseter domain patients saw their mean duration fall from ~20.1 2.9 weeks in controls to 17.3, 17.0, 16.7 and 16.2 weeks (hazard ratios 1.72-2.08) Sensitivity analysis suggested ~55% of the reduction in duration was attributable to synaptic modulation, ~30% to lean-mass decline, and ~15% to metabolic variability
Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients
Food and Drug Administration (FDA) to treat individuals with type 2 diabetes mellitus and obesity (BMI of 30 or greater) or overweight (BMI of 27 or greater) with at least one other weight-related medical condition